title: Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas.
authors.affiliation: Department of Sarcoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. spatel@mdanderson.org
authors.forename: S R
authors.initials: SR
authors.lastname: Patel
authors.forename: J
authors.initials: J
authors.lastname: Jenkins
authors.forename: N
authors.initials: N
authors.lastname: Papadopolous
authors.forename: M A
authors.initials: MA
authors.lastname: Burgess
authors.forename: C
authors.initials: C
authors.lastname: Plager
authors.forename: J
authors.initials: J
authors.lastname: Gutterman
authors.forename: R S
authors.initials: RS
authors.lastname: Benjamin
mesh_terms: D000328:Adult; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007890:Leiomyosarcoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C112567:etaracizumab